钻研者们曾试图用药物来逆转MDR，非细胞剂质的异专定(verapemil，VPL)能较着低落肿瘤细胞对新碱(vincristine，VCR)的耐药性[4，5]。
基于4个网页-相关网页
长春新碱 [药] Vincristine ; VCR ; Vinblastine ; Oncovin
麦角新碱 [药] ergometrine ; [药] ergonovine ; Methergine
硫酸长春新碱 Vincristine Sulphate ; VCR ; VincristineSulfateforInjection ; Vincristine Sulfate -Furen Pharm
长春新碱硫酸盐 Vincristine sulfate ; VincristinesulfateCAS
麦角异新碱 ergometrinine ; ergobasinine
注射用硫酸长春新碱 Vincristine Sulfate for Injection ; Vincristine Sulfate-Hualian
长春新碱脂质体 LVCR ; Vincristine liposome
唐松草新碱 Thalidasine
甲麦角新碱 Methylergonovine
结论：长循环脂质体是长春新碱的理想载体。
Conclusions: Long-circulating liposome is a good drug delivery system for vincristine.
例如硫酸长春新碱、酒石酸长春瑞宪，NHDC。
Such as Vincristine Sulfate, Vinorelbine Bitartrate, NHDC and Hesperidin Methyl Chalcone.
目的考察硫酸长春新碱脂质体的体外释放度及其药效。
Objective To investigate the release rate and pharmacodynamics in vitro of of vincristine sulfate liposomes.
应用推荐